Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3038

1.

Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy.

Motoya S, Watanabe M, Wallace K, Lazar A, Nishimura Y, Ozawa M, Thakkar R, Robinson AM, Singh RSP, Mostafa NM, Suzuki Y, Hibi T.

Inflamm Intest Dis. 2018 Jul;2(4):228-235. doi: 10.1159/000486786. Epub 2018 May 15.

2.

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.

Schneider AM, Weghuber D, Hetzer B, Entenmann A, Müller T, Zimmermann G, Schütz S, Huber WD, Pichler J.

BMC Gastroenterol. 2018 Sep 15;18(1):140. doi: 10.1186/s12876-018-0868-x.

3.

[Intraperitoneal cystic lymphangioma and Crohn's disease: an exceptional association].

Ameur WB, Kallel L, Maghrebi H, Haouet S, Filali A.

Pan Afr Med J. 2018 May 18;30:48. doi: 10.11604/pamj.2018.30.48.14601. eCollection 2018. French.

4.

Acute Myeloid Leukemia with Myelodysplasia-Related Changes in a Patient with Crohn's Disease Treated with Immunosuppressive Therapy.

Li B, Zhu Z, Long S, Li F, Zhu X, Liao W.

Case Rep Oncol. 2018 Aug 17;11(2):573-576. doi: 10.1159/000491573. eCollection 2018 May-Aug.

5.

β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease.

Mori K, Naganuma M, Mizuno S, Suzuki H, Kitazume MT, Shimamura K, Chiba S, Sugita A, Matsuoka K, Hisamatsu T, Kanai T.

Intest Res. 2018 Jul;16(3):384-392. doi: 10.5217/ir.2018.16.3.384. Epub 2018 Jul 27.

6.

Can IL-23 be a good target for ulcerative colitis?

Allocca M, Furfaro F, Fiorino G, Gilardi D, D'Alessio S, Danese S.

Best Pract Res Clin Gastroenterol. 2018 Feb - Apr;32-33:95-102. doi: 10.1016/j.bpg.2018.05.016. Epub 2018 May 23. Review.

PMID:
30060945
7.

Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.

Núñez-Gómez L, Mesonero-Gismero F, Albillos-Martínez A, López-Sanromán A.

Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30195-X. doi: 10.1016/j.gastrohep.2018.06.010. [Epub ahead of print] English, Spanish.

PMID:
30054143
8.

SERUM INFLIXIMAB MEASUREMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION: A COMPARATIVE ANALYSIS OF TWO DIFFERENT METHODS IN A MULTICENTRIC BRAZILIAN COHORT.

Teixeira FV, Sassaki LY, Saad-Hossne R, Baima JP, Magro DO, Coy CSR, Kotze PG.

Arq Gastroenterol. 2018 Apr-Jun;55(2):192-197. doi: 10.1590/S0004-2803.201800000-35.

9.

Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series.

Bär F, Krause T, Stallmach A, Teich N, Maaser C, Maul J, Helwig U, Fellermann K, Büning J; German IBD Study Group.

Inflamm Intest Dis. 2018 Mar;2(3):139-146. doi: 10.1159/000481820. Epub 2017 Nov 22.

10.

Recent trends (2016-2017) in the treatment of inflammatory bowel disease.

Masaki T, Kishiki T, Kojima K, Asou N, Beniya A, Matsuoka H.

Ann Gastroenterol Surg. 2018 Jun 2;2(4):282-288. doi: 10.1002/ags3.12177. eCollection 2018 Jul. Review.

11.

[Inflammatory Bowel Diseases - Diagnosis and Therapy in Practice].

Teich N, Klugmann T.

Dtsch Med Wochenschr. 2018 Jul;113(13):945-952. doi: 10.1055/a-0538-3715. Epub 2018 Jul 4. Review. German.

PMID:
29972838
12.

Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?

Mazieiro R, Frizon RR, Barbalho SM, Goulart RA.

J Med Food. 2018 Jun 29. doi: 10.1089/jmf.2017.0146. [Epub ahead of print]

PMID:
29957091
13.

Effect of a concomitant elemental diet with maintenance anti-tumor necrosis factor-α antibody therapy in patients with Crohn's disease: A multicenter, prospective cohort study.

Hirai F, Ishida T, Takeshima F, Yamamoto S, Yoshikawa I, Ashizuka S, Inatsu H, Mitsuyama K, Sou S, Iwakiri R, Nozaki R, Ohi H, Esaki M, Iida M, Matsui T; Additional Power of Elemental Diet on Maintenance Biologics Therapy in Crohn's Disease (ADORE) Study Group.

J Gastroenterol Hepatol. 2018 Jun 23. doi: 10.1111/jgh.14361. [Epub ahead of print]

PMID:
29935082
14.

Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report.

Bokemeyer A, Tentrop N, Barth PJ, Lenze F, Hengst K, Kleinheinz J, Bettenworth D.

BMC Gastroenterol. 2018 Jun 18;18(1):88. doi: 10.1186/s12876-018-0818-7.

15.

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease.

Zaidi D, Huynh HQ, Carroll MW, Baksh S, Wine E.

Clin Exp Gastroenterol. 2018 May 30;11:217-231. doi: 10.2147/CEG.S148217. eCollection 2018.

16.

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.

Dulai PS, Boland BS, Singh S, Chaudrey K, Koliani-Pace JL, Kochhar G, Parikh MP, Shmidt E, Hartke J, Chilukuri P, Meserve J, Whitehead D, Hirten R, Winters AC, Katta LG, Peerani F, Narula N, Sultan K, Swaminath A, Bohm M, Lukin D, Hudesman D, Chang JT, Rivera-Nieves J, Jairath V, Zou GY, Feagan BG, Shen B, Siegel CA, Loftus EV Jr, Kane S, Sands BE, Colombel JF, Sandborn WJ, Lasch K, Cao C.

Gastroenterology. 2018 Sep;155(3):687-695.e10. doi: 10.1053/j.gastro.2018.05.039. Epub 2018 May 30.

PMID:
29857091
17.

Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's Disease.

Dige A, Magnusson MK, Uhrenholt C, Rasmussen TK, Kragstrup T, Öhman L, Dahlerup J, Agnholt J.

Mediators Inflamm. 2018 Apr 26;2018:3279607. doi: 10.1155/2018/3279607. eCollection 2018.

18.

Crohn's disease of the vulva: A prospective study.

Bhoyrul B, Lyon C.

J Gastroenterol Hepatol. 2018 May 29. doi: 10.1111/jgh.14291. [Epub ahead of print]

PMID:
29845642
19.

Seronegative enteropathy and malnutrition: a diagnostic challenge.

McCulloch J, Barclay M, Levene A, Fearn R.

BMJ Case Rep. 2018 May 26;2018. pii: bcr-2018-224397. doi: 10.1136/bcr-2018-224397.

PMID:
29804077
20.

Obstructive Lymphangitis Precedes Colitis in Murine Norovirus-Infected Stat1-Deficient Mice.

Seamons A, Treuting PM, Meeker S, Hsu C, Paik J, Brabb T, Escobar SS, Alexander JS, Ericsson AC, Smith JG, Maggio-Price L.

Am J Pathol. 2018 Jul;188(7):1536-1554. doi: 10.1016/j.ajpath.2018.03.019. Epub 2018 May 18.

PMID:
29753791

Supplemental Content

Loading ...
Support Center